Press releases
- Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
- NeoGenomics to Introduce Comprehensive Lung Solution & Feature Hematopathology Services at ASCO, Offering Actionable Insights to Support Treatment Management
- NeoGenomics Reports First Quarter 2024 Results
- NeoGenomics Announces Senior Leadership Promotions
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
More ▼
Key statistics
As of last trade Neogenomics Inc (NG9:FRA) traded at 12.10, 9.01% above its 52-week low of 11.10, set on Oct 04, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.10 |
---|---|
High | 12.10 |
Low | 12.10 |
Bid | 12.20 |
Offer | 12.30 |
Previous close | 12.20 |
Average volume | 82.22 |
---|---|
Shares outstanding | 127.71m |
Free float | 126.08m |
P/E (TTM) | -- |
Market cap | 1.67bn USD |
EPS (TTM) | -0.6698 USD |
Data delayed at least 15 minutes, as of Jun 26 2024 07:01 BST.
More ▼